Ancora Advisors’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-121,488
| Closed | -$650K | – | 1342 |
|
2018
Q2 | $650K | Sell |
121,488
-27,612
| -19% | -$148K | 0.03% | 424 |
|
2018
Q1 | $745K | Sell |
149,100
-51,864
| -26% | -$259K | 0.03% | 388 |
|
2017
Q4 | $663K | Buy |
200,964
+9,686
| +5% | +$32K | 0.04% | 375 |
|
2017
Q3 | $717K | Buy |
191,278
+35,700
| +23% | +$134K | 0.04% | 386 |
|
2017
Q2 | $397K | Buy |
155,578
+50,378
| +48% | +$129K | 0.03% | 462 |
|
2017
Q1 | $274K | Buy |
+105,200
| New | +$274K | 0.02% | 525 |
|